C-terminal α1-antitrypsin peptides as pre-transplant biomarkers for chronic lung allograft dysfunction risk stratification - PubMed
3 hours ago
- #risk stratification
- #biomarkers
- #lung transplantation
- C-terminal α1-antitrypsin peptides can be measured before lung transplantation for early risk assessment of chronic lung allograft dysfunction (CLAD).
- The research uses a patented liquid chromatography–tandem mass spectrometry method for characterizing systemic inflammation.
- Key patents related to the technology are held by Jena University Hospital, with conflicts of interest disclosed for some authors.